Despite a $400 million impairment charge, analysts say the removal of a drug-device combo from its portfolio is not a huge ...

Like many tech stocks, Alphabet's (NASDAQ: GOOGL) (NASDAQ: GOOG) stock pulled back in recent months. Investors still question ...

Google has revealed its Gemini 2.5, which allows it to take a significant leap forward in the AI capabilities. Gemini 2.5 Pro ...

Biotech stocks took a hit after the sudden resignation of Dr. Peter Marks, head of the FDA’s Center for Biologics Evaluation ...

Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...

Google released what it calls a thinking model that takes users into its thought process to reveal assumptions and why it ...

The company explains that in AI, "reasoning" refers to a system's ability to analyze information, draw logical conclusions ..

This thinking capability was first introduced by Google in its Gemini 2.0 Flash Thinking Experimental AI model, which was ...

Vertex has appointed a new commercial head for ... Orkambi in other countries – most recently Australia, where it is drawing up a results-based managed access agreement with health officials.

The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...

It refers to its ability to analyze information, draw logical conclusions ... in the Gemini app for Advanced users (who pay ...

Google describes Gemini 2.5 as a “thinking model”, capable of reasoning through its processes before responding, leading to ...